A detailed history of First Trust Advisors LP transactions in Sanofi stock. As of the latest transaction made, First Trust Advisors LP holds 851,297 shares of SNY stock, worth $40.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
851,297
Previous 959,909 11.31%
Holding current value
$40.6 Million
Previous $46.6 Million 5.39%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$48.54 - $58.53 $5.27 Million - $6.36 Million
-108,612 Reduced 11.31%
851,297 $49.1 Million
Q2 2024

Aug 13, 2024

SELL
$45.39 - $50.36 $9.81 Million - $10.9 Million
-216,055 Reduced 18.37%
959,909 $46.6 Million
Q1 2024

May 13, 2024

SELL
$45.75 - $52.48 $8.19 Million - $9.4 Million
-179,069 Reduced 13.22%
1,175,964 $57.2 Million
Q4 2023

Feb 13, 2024

BUY
$43.13 - $54.79 $5.48 Million - $6.96 Million
127,006 Added 10.34%
1,355,033 $67.4 Million
Q3 2023

Nov 13, 2023

SELL
$50.95 - $55.2 $4.36 Million - $4.73 Million
-85,610 Reduced 6.52%
1,228,027 $65.9 Million
Q2 2023

Aug 14, 2023

SELL
$50.45 - $57.18 $3.66 Million - $4.15 Million
-72,620 Reduced 5.24%
1,313,637 $70.8 Million
Q1 2023

May 15, 2023

SELL
$45.86 - $54.45 $6.92 Million - $8.22 Million
-150,938 Reduced 9.82%
1,386,257 $75.4 Million
Q4 2022

Feb 09, 2023

SELL
$38.86 - $48.55 $4.74 Million - $5.93 Million
-122,063 Reduced 7.36%
1,537,195 $74.4 Million
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $15.2 Million - $41 Million
408,171 Added 32.63%
1,659,258 $63.1 Million
Q2 2022

Aug 12, 2022

SELL
$48.99 - $57.46 $778,696 - $913,326
-15,895 Reduced 1.25%
1,251,087 $62.6 Million
Q1 2022

May 13, 2022

SELL
$48.48 - $53.65 $1.3 Million - $1.43 Million
-26,742 Reduced 2.07%
1,266,982 $65 Million
Q4 2021

Feb 08, 2022

SELL
$47.07 - $52.35 $403,013 - $448,220
-8,562 Reduced 0.66%
1,293,724 $64.8 Million
Q3 2021

Nov 15, 2021

BUY
$47.89 - $53.12 $8.67 Million - $9.62 Million
181,134 Added 16.16%
1,302,286 $62.8 Million
Q2 2021

Aug 16, 2021

SELL
$49.36 - $54.25 $2.93 Million - $3.21 Million
-59,261 Reduced 5.02%
1,121,152 $59 Million
Q1 2021

May 14, 2021

BUY
$45.46 - $50.51 $1.59 Million - $1.77 Million
34,959 Added 3.05%
1,180,413 $58.4 Million
Q4 2020

Feb 02, 2021

BUY
$45.3 - $51.62 $5.11 Million - $5.83 Million
112,907 Added 10.93%
1,145,454 $55.7 Million
Q3 2020

Nov 05, 2020

BUY
$49.47 - $53.77 $7.36 Million - $8 Million
148,716 Added 16.83%
1,032,547 $51.8 Million
Q2 2020

Jul 22, 2020

BUY
$42.91 - $52.5 $575,423 - $704,025
13,410 Added 1.54%
883,831 $45.1 Million
Q1 2020

May 06, 2020

SELL
$38.02 - $51.66 $3.69 Million - $5.01 Million
-97,034 Reduced 10.03%
870,421 $38.1 Million
Q4 2019

Feb 03, 2020

BUY
$44.25 - $50.86 $3.29 Million - $3.78 Million
74,347 Added 8.32%
967,455 $48.6 Million
Q3 2019

Nov 04, 2019

BUY
$40.34 - $46.64 $4.51 Million - $5.21 Million
111,701 Added 14.29%
893,108 $41.4 Million
Q2 2019

Jul 30, 2019

BUY
$40.43 - $44.3 $4.59 Million - $5.03 Million
113,551 Added 17.0%
781,407 $33.8 Million
Q1 2019

May 09, 2019

BUY
$40.83 - $45.43 $3.85 Million - $4.28 Million
94,281 Added 16.44%
667,856 $29.6 Million
Q4 2018

Feb 07, 2019

BUY
$41.48 - $45.59 $1.09 Million - $1.2 Million
26,283 Added 4.8%
573,575 $24.9 Million
Q3 2018

Oct 25, 2018

BUY
$40.0 - $44.84 $834,960 - $935,990
20,874 Added 3.97%
547,292 $24.4 Million
Q2 2018

Aug 02, 2018

BUY
$37.63 - $41.22 $149,014 - $163,231
3,960 Added 0.76%
526,418 $21.1 Million
Q1 2018

Apr 23, 2018

BUY
$38.98 - $45.76 $228,071 - $267,741
5,851 Added 1.13%
522,458 $20.9 Million
Q4 2017

Feb 08, 2018

BUY
$42.86 - $50.61 $4.7 Million - $5.55 Million
109,613 Added 26.93%
516,607 $22.2 Million
Q3 2017

Oct 24, 2017

BUY
$47.04 - $50.34 $19.1 Million - $20.5 Million
406,994
406,994 $20.3 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.